Introduction: Rapid and effective host cell invasion and vascularization is essential for durable incorporation of avascular tissue-replacement scaffolds. In this study, we sought to qualitatively and quantitatively determine which of the two widely applied commercially-available products Strattice ® and Integra ® (1-5) facilitate more rapid cellular and vascular invasion in a murine model of graft incorporation.
Methods: Four 8mm discs of Integra ® and Strattice ® were implanted subcutaneously in the dorsa of C57BL/6 mice, harvested after 3, 7, or 14 days, and stained with hematoxylin & eosin, DAPI, and immunohistochemical (IHC) stains for CD31 and α-smooth muscle actin (αSMA). Exponential decay equations describing cellular invasion through each layer were fit to each material/time point. Mean cell density and cell frequency maps were created denoting extent of invasion by location within the scaffold.
Results: Qualitative analyses demonstrated diffuse and extensive cellular infiltration into Integra
® by day 3 and increasing over the 2-week period. Invasion of Strattice ® was patchy and sparse, even after 14 days. IHC staining for αSMA revealed blood vessel formation within Integra ® by day 14 (Figure 1 ), but no analogous neovascularization in Strattice ® (Figure 2 ). Cell density measurements showed that at all time points, Integra ® manifested a greater density and depth of cellular invasion as compared with Strattice ® , a finding confirmed by cell frequency mapping. 
Conclusions: These data confirm empiric clinical observations that Integra
® is more rapidly invaded than Strattice ® when placed in a suitable host bed. A remnant microvasculature template is not sufficient for effective cellular ingrowth into an artificial tissue construct. These findings provide insight into means for improving future dermal replacement products.
